Korro Bio Inc
(KRRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,643 | 166,150 | 36,333 | 79,635 | 220,341 |
| Marketable Securities | 70,452 | N/A | 18,915 | 51,072 | N/A |
| Receivables | 1,696 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 3,563 | 603 | 0 | 0 |
| TOTAL | $131,532 | $172,728 | $57,083 | $134,748 | $225,064 |
| Non-Current Assets | |||||
| PPE Net | 27,710 | 15,665 | 9,866 | 5,522 | 7,287 |
| Investments And Advances | 36,959 | 0 | 0 | 11,719 | 0 |
| Other Non-Current Assets | 30,039 | 33,270 | 6,793 | 33,369 | 32,371 |
| TOTAL | $94,708 | $48,935 | $16,659 | $50,610 | $39,658 |
| Total Assets | $226,240 | $221,663 | $73,742 | $185,358 | $264,722 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 833 | N/A |
| Accounts payable and accrued liabilities | 3,992 | 7,280 | 2,605 | 2,748 | 5,506 |
| Accrued Expenses | 6,171 | 10,212 | 3,175 | 6,101 | 6,663 |
| TOTAL | $14,960 | $19,483 | $8,701 | $11,429 | $26,634 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 14,167 | 15,000 |
| Deferred Revenues | 3,513 | N/A | N/A | N/A | 14,068 |
| Other Non-Current Liabilities | 44,953 | 32,269 | 209 | 28,938 | 30,597 |
| TOTAL | $50,865 | $32,269 | $209 | $43,105 | $45,597 |
| Total Liabilities | $65,825 | $51,752 | $8,910 | $54,534 | $72,231 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,389 | 8,022 | 706 | 700 | 684 |
| Common Shares | 9 | 8 | N/A | 35 | 34 |
| Retained earnings | -266,586 | -183,005 | -101,833 | -180,085 | -95,399 |
| Other shareholders' equity | 268 | 0 | 163,858 | -62 | 27 |
| TOTAL | $160,415 | $169,911 | $64,832 | $130,824 | $192,491 |
| Total Liabilities And Equity | $226,240 | $221,663 | $73,742 | $185,358 | $264,722 |